Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada (Q37247986)
Jump to navigation
Jump to search
scientific article published on October 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada |
scientific article published on October 2013 |
Statements
1 reference
Cost-effectiveness of lapatinib plus letrozole in her2-positive, hormone receptor-positive metastatic breast cancer in Canada (English)
1 reference
T E Delea
1 reference
J Amdahl
1 reference
A Chit
1 reference
M M Amonkar
1 reference
1 October 2013
1 reference
1 reference
e371-87
1 reference
1 October 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference